Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 14/20 | 0.42 |
| ▸ | MMP1 | P03956 | 9/20 | 0.42 |
| ▸ | MMP3 | P08254 | 9/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | MMP7 | P09237 | 4/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8387575 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8385145 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL2392222 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8386222 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL25283495 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL1684230 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL25287896 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL2394133 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL337801 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A | |
| SCHEMBL8381675 | 1.00 | CSNK1E (0.55) | CSNK1EMMP2MMP1MMP3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5955584-A | NON-PROTEIN ANTIGEN COMPOSED OF STEROID COMPONENT WITH 3 BETA HYDROXY OR 3 KETO GROUP AND QUATERNARY AMMONIUM SALT; FOR THERAPY AND IMMUNOASSAY DIAGNOSIS | CHARTER VENTURES (US) | 1999-09-21 | — | — | US | disclosed |
| US-5811248-A | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof | CHARTER VENTURES (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0707489-A4 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS INC (US) | 1998-07-29 | — | — | EP | disclosed |
| EP-0707489-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | Scotgen Biopharmaceuticals, Inc. (US) | 1996-04-24 | — | — | EP | disclosed |
| WO-1994025053-A1 | ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF | SCOTGEN BIOPHARMACEUTICALS, INC. (US) | 1994-11-10 | — | — | WO | disclosed |